Financials in USD. Standardized financial statements.
A compact view of how Miromatrix Medical Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Revenue? | $953,470 | $33,066 | $46,530 | $250,000 |
| Revenue Growth? | +2783.5% | -28.9% | -81.4% | 0.0% |
| Cost of Revenue? | $500,000 | $500,000 | $500,000 | $250,000 |
| Gross Profit? | $453,470 | -$466,934 | -$453,470 | $0 |
| Gross Margin? | +47.6% | -1412.1% | -974.6% | 0.0% |
| Operating Expenses? | $30.70M | $16.10M | $8.81M | $8.56M |
| Operating Income? | -$30.25M | -$16.96M | -$10.26M | -$8.99M |
| EBITDA? | -$29.70M | -$13.83M | -$11.45M | -$9.13M |
| Income Before Tax | -$29.96M | -$14.67M | -$10.31M | -$9.53M |
| Income Tax Expense | $47,835 | $284,980 | -$1.59M | -$6.46M |
| Net Income? | -$30.01M | -$14.96M | -$8.72M | -$3.07M |
| EPS? | $-1.45 | $-0.73 | $-0.82 | $-0.29 |
| Diluted EPS? | $-1.45 | $-0.73 | $-0.82 | $-0.29 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality